×
About 14,929 results

ALLMedicine™ Idiopathic Pulmonary Fibrosis Center

Research & Reviews  7,115 results

Ergogenic Value of Oxygen Supplementation in Patients with Idiopathic Pulmonary Fibrosi...
https://doi.org/10.1159/000515397
Respiration; International Review of Thoracic Diseases; Vogiatzis I, Bouros D

Apr 13th, 2021 - Ergogenic Value of Oxygen Supplementation in Patients with Idiopathic Pulmonary Fibrosis with Isolated Exertional Oxygen Desaturation.|2021|Vogiatzis I,Bouros D,|

Exercise Testing in Idiopathic Pulmonary Fibrosis: Expanding Our Options.
https://doi.org/10.1159/000515665
Respiration; International Review of Thoracic Diseases; Mura M, Bouros D

Apr 13th, 2021 - Exercise Testing in Idiopathic Pulmonary Fibrosis: Expanding Our Options.|2021|Mura M,Bouros D,|

Concurrence of 1- and 3-Min Sit-to-Stand Tests with the 6-Min Walk Test in Idiopathic P...
https://doi.org/10.1159/000515335
Respiration; International Review of Thoracic Diseases; Fedi A, Keddache S et. al.

Apr 13th, 2021 - In idiopathic pulmonary fibrosis (IPF), some physiological parameters measured during a 6-min walk test (6-MWT) impart reliable prognostic information. Sit-to-stand tests (STSTs) are field exercise tests that are easier to implement than the 6-MWT...

There is detectable variation in the lipidomic profile between stable and progressive p...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033725
Respiratory Research; Nambiar S, Clynick B et. al.

Apr 10th, 2021 - Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterized by fibrosis and progressive loss of lung function. The pathophysiological pathways involved in IPF are not well understood. Abnormal lipid metabolism has been...

Action plans in idiopathic pulmonary fibrosis: a qualitative study-'I do what I can do'.
https://doi.org/10.1136/bmjspcare-2020-002831
BMJ Supportive & Palliative Care; Kalluri M, Younus S et. al.

Apr 9th, 2021 - Idiopathic pulmonary fibrosis (IPF) is a progressive, incurable fibrotic lung disease in which patients and caregivers report a high symptom burden. Symptoms are often poorly managed and patients and caregivers struggle to alleviate their distress...

see more →

Guidelines  19 results

S2K Guideline for Diagnosis of Idiopathic Pulmonary Fibrosis.
https://doi.org/10.1159/000512315
Respiration; International Review of Thoracic Diseases; Behr J, Günther A et. al.

Jan 24th, 2021 - Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease. Diagnosis of IPF requires considerable expertise and experience. Since the publication of the international IPF guideline in the year 2011 and the update 2018 several studies...

Guidelines of the Polish Respiratory Society for diagnosis and treatment of idiopathic ...
https://doi.org/10.5603/ARM.2020.0081
Advances in Respiratory Medicine; Piotrowski WJ, Bestry I et. al.

Mar 10th, 2020 - This document presents the guidelines of the Polish Respiratory Society (PTChP, Polskie Towarzystwo Chorób Płuc) for diagnosis and treatment of idiopathic pulmonary fibrosis (IPF), developed by agroup of Polish experts. The recommendations were de...

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice G...
https://www.atsjournals.org/doi/10.1164/rccm.201807-1255ST
Raghu, G.

Aug 31st, 2018 - This document provides clinical recommendations for the diagnosis of idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and.

Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fib...
http://www.thoracic.org/statements/resources/interstitial-lung-disease/animal-models-pulm-fibrosis.pdf
R. Gisli Jenkins

Apr 30th, 2017 - Numerous compounds have shown efficacy in limiting development of pulmonary fibrosis using animal models, yet few of these compounds have replicated these beneficial effects in clinical trials. Given the challenges associated with performing clini.

Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment.
https://doi.org/10.1159/000464332
Respiration; International Review of Thoracic Diseases; Funke-Chambour M, Azzola A et. al.

Mar 27th, 2017 - Idiopathic pulmonary fibrosis (IPF) is a severe progressive and irreversible lung disease. Novel antifibrotic drugs that slow disease progression are now available. However, many issues regarding patient management remain unanswered, such as the c...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  7,411 results

Ergogenic Value of Oxygen Supplementation in Patients with Idiopathic Pulmonary Fibrosi...
https://doi.org/10.1159/000515397
Respiration; International Review of Thoracic Diseases; Vogiatzis I, Bouros D

Apr 13th, 2021 - Ergogenic Value of Oxygen Supplementation in Patients with Idiopathic Pulmonary Fibrosis with Isolated Exertional Oxygen Desaturation.|2021|Vogiatzis I,Bouros D,|

Exercise Testing in Idiopathic Pulmonary Fibrosis: Expanding Our Options.
https://doi.org/10.1159/000515665
Respiration; International Review of Thoracic Diseases; Mura M, Bouros D

Apr 13th, 2021 - Exercise Testing in Idiopathic Pulmonary Fibrosis: Expanding Our Options.|2021|Mura M,Bouros D,|

Concurrence of 1- and 3-Min Sit-to-Stand Tests with the 6-Min Walk Test in Idiopathic P...
https://doi.org/10.1159/000515335
Respiration; International Review of Thoracic Diseases; Fedi A, Keddache S et. al.

Apr 13th, 2021 - In idiopathic pulmonary fibrosis (IPF), some physiological parameters measured during a 6-min walk test (6-MWT) impart reliable prognostic information. Sit-to-stand tests (STSTs) are field exercise tests that are easier to implement than the 6-MWT...

There is detectable variation in the lipidomic profile between stable and progressive p...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033725
Respiratory Research; Nambiar S, Clynick B et. al.

Apr 10th, 2021 - Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterized by fibrosis and progressive loss of lung function. The pathophysiological pathways involved in IPF are not well understood. Abnormal lipid metabolism has been...

Action plans in idiopathic pulmonary fibrosis: a qualitative study-'I do what I can do'.
https://doi.org/10.1136/bmjspcare-2020-002831
BMJ Supportive & Palliative Care; Kalluri M, Younus S et. al.

Apr 9th, 2021 - Idiopathic pulmonary fibrosis (IPF) is a progressive, incurable fibrotic lung disease in which patients and caregivers report a high symptom burden. Symptoms are often poorly managed and patients and caregivers struggle to alleviate their distress...

see more →

News  375 results

Fast Five Quiz: Diagnosing Idiopathic Pulmonary Fibrosis
https://reference.medscape.com/viewarticle/909154

Feb 3rd, 2021 - Idiopathic pulmonary fibrosis (IPF) is the most common form of chronic, progressive fibrosing interstitial pneumonia of unknown origin. The histopathology and radiological findings of IPF are the same as those of usual interstitial pneumonia (UIP)...

PPI Use Not Associated With Improved Survival in Idiopathic Pulmonary Fibrosis
https://www.staging.medscape.com/viewarticle/936990

Sep 7th, 2020 - Takeaway In patients with idiopathic pulmonary fibrosis (IPF), the use of proton pump inhibitors (PPIs) is not associated with improved survival and reduced incidence of respiratory-related hospitalisation compared with non-use. Why this matters F...

PPI Use Not Associated With Improved Survival in Idiopathic Pulmonary Fibrosis
https://www.medscape.com/viewarticle/936990

Sep 7th, 2020 - Takeaway In patients with idiopathic pulmonary fibrosis (IPF), the use of proton pump inhibitors (PPIs) is not associated with improved survival and reduced incidence of respiratory-related hospitalisation compared with non-use. Why this matters F...

Fast Five Quiz: Idiopathic Pulmonary Fibrosis Comorbidities and Complications
https://reference.medscape.com/viewarticle/925460_5

Jul 12th, 2020 - An increased prevalence of both OSA and GERD has been noted in patients with IPF. However, OSA has not been found to be a risk factor for GERD among patients with IPF. The use of GERD medications has been associated with longer survival times and ...

Fast Five Quiz: Idiopathic Pulmonary Fibrosis Comorbidities and Complications
https://reference.medscape.com/viewarticle/925460_6

Jul 12th, 2020 - Approximately 30% of patients with IPF have comorbid emphysema. The presence of comorbid emphysema does not disqualify patients with IPF for consideration or evaluation for lung transplantation. Comorbid emphysema is more commonly seen in men with...

see more →

Patient Education  5 results see all →